InVivo Therapeutics Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) announces that Richard Toselli, M.D., President and CEO, will present at the M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference from March 17 – March 19, 2021. The presentation aims to provide an overview of the company and discuss key business updates. A webcast will be available for registered attendees starting March 17 at 9:00 am ET. The company focuses on treating spinal cord injuries, utilizing proprietary technology co-invented by leading figures in the field.
- Participation in a virtual conference may enhance visibility and investor interest.
- Presentation by the CEO can provide insights into future growth strategies.
- None.
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, which runs from March 17 – March 19 from 9:00 am – 5:00 pm ET. Dr. Toselli’s presentation will provide an overview of the company and highlight key business updates for the company.
A webcast of the presentation will be available for registered conference attendees starting March 17 at 9:00 am at https://www.m-vest.com/events/2021-emerging-growth-virtual-conference.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. The publicly traded company is headquartered in Cambridge, MA. For more details, visit www.invivotherapeutics.com.
About M Vest LLC
M Vest LLC is an online investment bank and digital community built for issuers, investors, and thought leaders to share information and access investment opportunities through capital raisings of Regulation D and Regulation A Offerings. Founded in 2017 and headquartered in New York City, M-Vest provides insights on current equity market trends, hosts presentations from public companies, and provides access to capital for emerging growth companies. M-Vest hosts live conferences and webinars featuring CEOs discussing the latest developments in their industries. M Vest LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC), is a member of FINRA and SIPC, and is a sister company of Maxim Group, LLC.
About Maxim Group LLC
Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed- income and derivatives sales & trading, equity research and prime brokerage services. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB). Member of FINRA SIPC, and NASDAQ. To learn more about Maxim Group, visit maximgrp.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210312005056/en/
FAQ
When is InVivo Therapeutics presenting at the virtual conference?
Who is the CEO of InVivo Therapeutics?
What is the focus of InVivo Therapeutics?
Where can I watch the InVivo Therapeutics presentation?
What is the key technology behind InVivo Therapeutics?
